Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.557
Filter
1.
Arq. bras. oftalmol ; 86(1): 33-37, Jan.-Feb. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1403475

ABSTRACT

ABSTRACT Purpose: This study measured fecal calprotectin levels in a series of patients with anterior uveitis in order to determine whether anterior uveitis patients with associated spondyloarthritis have higher levels of fecal calprotectin than patients with anterior uveitis of other etiologies. A third group of patients with spondyloarthritis without uveitis was also evaluated to understand the role of acute anterior uveitis in increasing fecal calprotectin. Methods: In this cross-sectional study, 28 patients were divided into three groups: (a) Group 1, spondyloarthritis and uveitis (n=9); (b) Group 2, spondyloarthritis without uveitis (n=10); and (c) Group 3, uveitis without spondyloarthritis (n=9). The levels of fecal calprotectin were determined. Results: Groups 1 and 2 showed higher median fecal calprotectin levels (101.0 and 93.0 µg/g, respectively) compared with Group 3 (9.0 µg/g) (p=0.02). However, no relationship between fecal calprotectin levels and the presence of uveitis with spondyloarthritis could be demonstrated. Conclusion: Patients with spondyloarthritis with or without acute anterior uveitis have significantly elevated levels of fecal calprotectin. This test may be useful for differentiating spondyloarthrit-associated uveitis from uveitis of other etiologies.


RESUMO Objetivo: Este estudo avaliou os níveis de calprotectina fecal em uma série de pacientes com uveíte anterior na tentativa de determinar se pacientes com uveíte associada com espondiloartrites apresentam níveis mais elevados desta proteína do que pacientes com uveíte anterior de outras etiologias. Um terceiro grupo com espondiloartrites sem uveíte também foi incluído na avaliação para entendimento do papel da uveíte anterior no aumento da calprotectina fecal. Métodos: Estudo transversal de 28 pacientes divididos em três grupos: (a) com espondiloartrites e uveíte (n=9); (b) com espondiloartrites sem uveíte (n=10) e (c) com uveíte sem espondiloartrites (n=9). A dosagem de calprotectina fecal foi avaliada. Resultados: Pacientes com uveíte anterior associada a espondiloartrites apresentaram valores medianos maiores de calprotectina fecal (101 µg/g) que os valores dos pacientes com uveíte sem espondiloartrites (9 µg/g), pacientes com espondiloartrites sem uveíte que também demonstraram valores maiores (93.0 µg/g) que os dos pacientes com uveíte sem espondiloartrites (p=0,02). Conclusão: Pacientes com espondiloartrites com e sem uveíte anterior aguda demonstraram níveis significativamente elevados de calprotectina fecal. Este teste pode ser útil na diferenciação entre uveítes associadas com espondiloartrites de uveítes de outras etiologias. Entretanto, não foi possível demonstrar associação entre o aumento dos níveis de calprotectina fecal e a presença da uveíte em espondiloartrites.

2.
Rev. bras. med. esporte ; 29: e2022_0318, 2023. tab, graf
Article in English | LILACS | ID: biblio-1407661

ABSTRACT

ABSTRACT Introduction: Athletes' physical conditioning is closely related to the type of sport dedicated, training levels, intrinsic conditions of the athletes, type of load, and recovery status after exercise training. There is ample documentation on the physical conditioning of volleyball athletes in normal situations, but the literature is lacking in surveys during competition periods. Objective: To explore the physical conditioning through analysis of body biomarkers in volleyball athletes in competition. Methods: Before and after the summer training, fasting urine and blood samples were collected from five female volleyball players. Biomarkers involving white blood cells, red blood cells, hemoglobin, etc., were detected, recorded, and the data were statistically analyzed. After the general analysis of the sample, a case study of two elite female athletes was conducted. Results: The urea nitrogen value of athlete A decreased from 7.62mmol/L to 4.91mmol/L, and the urea nitrogen value of athlete B decreased from 6.91mmol/L to 6.57mmol/L; the urea nitrogen values of both athletes showed a downward trend. Athlete A's physical function status decreased significantly after summer training, while Athlete B's physical function status improved slightly. Conclusion: During the summer training period, it is necessary to perform continuous index measurements on the athletes to increase the timeliness of the data, which is conducive to in-depth analysis of the athletes' fitness status. Level of evidence II; Therapeutic studies - investigation of treatment outcomes.


RESUMO Introdução: O condicionamento físico dos atletas está intimamente relacionado ao tipo de esporte dedicado, níveis de treinamento, condições intrínsecas das atletas, tipo de carga e status de recuperação após o treinamento dos exercícios. Há vasta documentação sobre o condicionamento físico dos atletas de vôlei em situações normais, porém a literatura deixa a desejar nos levantamentos durante o período de competições. Objetivo: Explorar o condicionamento físico através de análise de biomarcadores corporais nos atletas de vôlei em competição. Métodos: Antes e depois do período de treinamento de verão, foram coletadas amostras de urina e sangue, em jejum, de cinco jogadoras de vôlei feminino. Biomarcadores envolvendo glóbulos brancos, glóbulos vermelhos, hemoglobina, etc. foram detectados, registrados, e os dados foram analisados estatisticamente. Após a análise geral da amostra, foi realizado um estudo de caso de duas atletas de elite. Resultados: O valor de nitrogênio de ureia da atleta A diminuiu de 7,62mmol/L para 4,91mmol/L, e o valor do nitrogênio de ureia da atleta B diminuiu de 6,91mmol/L para 6,57mmol/L, os valores de nitrogênio da ureia de ambas as atletas apresentaram tendência de queda. O estado de função física da atleta A diminuiu significativamente após os treinos de verão, enquanto o estado de função física da atleta B melhorou ligeiramente. Conclusão: Durante o período de treinamento de verão, é necessário realizar uma medição contínua do índice sobre os atletas para aumentar a pontualidade dos dados, o que é propício à análise aprofundada do estado de condicionamento físico das atletas. Nível de evidência II; Estudos terapêuticos - investigação dos resultados do tratamento.


RESUMEN Introducción: El acondicionamiento físico de los deportistas está íntimamente relacionado con el tipo de deporte al que se dedican, los niveles de entrenamiento, las condiciones intrínsecas de los deportistas, el tipo de carga y el estado de recuperación tras los ejercicios de entrenamiento. Existe una amplia documentación sobre el acondicionamiento físico de los deportistas de voleibol en situaciones normales, pero la literatura deja mucho que desear en los estudios durante el periodo de competiciones. Objetivo: Explorar la condición física mediante el análisis de biomarcadores corporales en atletas de voleibol en competición. Métodos: Antes y después del periodo de entrenamiento de verano, se recogieron muestras de orina y sangre en ayunas de cinco jugadoras de voleibol. Se detectaron y registraron los biomarcadores relativos a los glóbulos blancos, los glóbulos rojos, la hemoglobina, etc., y los datos se analizaron estadísticamente. Tras el análisis general de la muestra, se realizó un estudio de casos de dos atletas de élite. Resultados: El valor de nitrógeno ureico del atleta A disminuyó de 7.62mmol/L a 4.91mmol/L, y el valor de nitrógeno ureico del atleta B disminuyó de 6.91mmol/L a 6.57mmol/L, los valores de nitrógeno ureico de ambos atletas mostraron una tendencia a la baja. El estado de la función física del atleta A disminuyó significativamente después del entrenamiento de verano, mientras que el estado de la función física del atleta B mejoró ligeramente. Conclusión: Durante el período de entrenamiento de verano, es necesario realizar mediciones continuas de los índices en los atletas para aumentar la puntualidad de los datos, lo que favorece el análisis en profundidad del estado de forma física de los atletas.Nivel de evidencia II; Estudios terapéuticos - investigación de los resultados del tratamiento.


Subject(s)
Humans , Female , Adult , Young Adult , Biomarkers/analysis , Volleyball , Athletes , Physical Conditioning, Human
3.
Rev. bras. med. esporte ; 29: e2022_0244, 2023. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1407647

ABSTRACT

ABSTRACT Introduction The relevance in studying the characteristics of biochemical markers on the training process of volleyball players is conditioned to the specificity of these parameters for such sport, considering the degree and nature of physical activity mostly in open kinetic chain. Objective To select the most relevant biomarkers for strength training in volleyball athletes and to verify their consistency with other biochemical status parameters. Methods A review of the scientific and methodological literature in the field of volleyball training was performed and the biochemicals were tested with statistical-mathematical methods. The optimal set of biochemical markers for an effective control of the training process in open kinetic chain sport was established, which can be used to evaluate the tolerability of training loads in several of its stages. Results Effective clinical and laboratory tests were determined to solve medical and biological monitoring tasks in the training process. The possibility of using biochemical control data to assess the prospects of a high level of functional status in the pre-competition period was demonstrated. Conclusion The results obtained can be used as part of the medical and biological support in the training process of volleyball athletes, and can be introduced in national medical and biological subject cycles. Evidence level II; Therapeutic studies - outcomes research.


RESUMO Introdução A relevância no estudo das características dos marcadores bioquímicos sobre o processo de treinamento dos jogadores de voleibol está condicionada à especificidade desses parâmetros para tal esporte, considerando o grau e a natureza da atividade física majoritariamente em cadeia cinética aberta. Objetivo Selecionar os biomarcadores mais relevantes para treinamento de força em atletas de voleibol e verificar a sua consistência com outros parâmetros do status bioquímico. Métodos Efetuou-se uma análise da literatura científica e metodológica no campo do ensino do voleibol e os bioquímicos foram testados com métodos estatístico-matemáticos. Foi estabelecido o conjunto ideal de marcadores bioquímicos para um controle eficaz do processo de treinamento no esporte de cadeia cinética aberta, que pode ser usado para avaliar a tolerabilidade das cargas de treinamento em várias de suas etapas. Resultados Foram determinados testes clínicos e laboratoriais eficazes para resolver tarefas de monitoramento médico e biológico no processo de treinamento. Foi demonstrada a possibilidade de utilizar dados de controle bioquímico para avaliar as perspectivas de um alto nível de estado funcional no período pré-competição. Conclusão Os resultados obtidos podem ser utilizados como parte do suporte médico e biológico no processo de treinamento de atletas de vôlei, podendo ser introduzidos em ciclos de disciplinas médicas e biológicas nacionais. Evidência nível II; Estudos terapêuticos - pesquisa de resultados.


RESUMEN Introducción La relevancia en el estudio de las características de los marcadores bioquímicos sobre el proceso de entrenamiento de los jugadores de voleibol está condicionada a la especificidad de estos parámetros para dicho deporte, considerando el grado y la naturaleza de la actividad física sobre todo en cadena cinética abierta. Objetivo Seleccionar los biomarcadores más relevantes para el entrenamiento de fuerza en deportistas de voleibol y verificar su consistencia con otros parámetros del estado bioquímico. Métodos Se realizó una revisión de la literatura científica y metodológica en el campo del entrenamiento del voleibol y se comprobaron los bioquímicos con métodos estadístico-matemáticos. Se estableció el conjunto ideal de marcadores bioquímicos para un control eficaz del proceso de entrenamiento en el deporte de cadena cinética abierta, que puede utilizarse para evaluar la tolerabilidad de las cargas de entrenamiento en varias de sus etapas. Resultados Se determinaron pruebas clínicas y de laboratorio eficaces para resolver las tareas de seguimiento médico y biológico en el proceso de formación. Se demostró la posibilidad de utilizar los datos de control bioquímico para evaluar las perspectivas de un alto nivel de estado funcional en el período previo a la competición. Conclusión Los resultados obtenidos pueden ser utilizados como parte del apoyo médico y biológico en el proceso de entrenamiento de los atletas de voleibol, y pueden ser introducidos en los ciclos de las disciplinas médicas y biológicas nacionales. Nivel de evidencia II; Estudios terapéuticos - investigación de resultados.

4.
Säo Paulo med. j ; 140(6): 818-828, Nov.-Dec. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1410223

ABSTRACT

Abstract BACKGROUND: Chronically elevated alpha-2-macroglobulin (A2MG) in the blood has been correlated with diabetes and the HbA1c profile; however, no systematic review has been conducted to evaluate the association of A2MG salivary levels and glycemia or HbA1c levels in diabetes mellitus type 2 (DM2) patients. OBJECTIVE: To evaluate whether A2MG salivary levels are related to the glycemia or HbA1c levels in DM2 patients. DESIGN AND SETTING: Systematic review developed at Universidade Federal de Uberlândia (UFU), Brazil. METHODS: Eight databases were used as research sources. The eligibility criteria included studies that reported data regarding mean salivary A2MG and the correlation between glycemia and/or HbA1c levels of DM2 subjects (uncontrolled and well-controlled) and non-diabetic subjects. The risk of bias of the studies selected was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools for use in JBI systematic reviews. Pooled correlation coefficients were estimated using the Hunter-Schmidt method. Study estimates were weighted according to their sample size, and heterogeneity was calculated using the chi-square statistic. RESULTS: Four studies on DM2 patients were included in this systematic review after careful analysis of 1482 studies. Three studies compared A2MG with HbA1c and glycemia. Overall, the correlation between A2MG and HbA1c was strong (r = 0.838). In contrast, the correlation between A2MG and glycemia was low (r = 0.354). CONCLUSION: The strong association between HbA1C and salivary A2MG suggests that this salivary protein has the potential to be a surrogate for HbA1C, if corroboratory further evidence is obtained through large-scale studies.

5.
Arq. bras. cardiol ; 119(5): 747-753, nov. 2022. tab, graf
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1403380

ABSTRACT

Resumo Fundamento Não está claro se o exercício é seguro em pacientes com formas mais avançadas de doença arterial coronariana, como aqueles com angina refratária (AR). Objetivo Visamos determinar o efeito de uma sessão de exercício aeróbico agudo (SEAA) nos níveis de troponina T cardíaca de alta sensibilidade (TnT-as) em pacientes com AR. Métodos Trata-se de um estudo clínico longitudinal, não randomizado e não controlado. Os participantes foram recrutados de abril de 2015 a janeiro de 2019. Em uma escala visual de dor de 0 a 10, a dor classificada até 3 foi considerada como o nível máximo permitido para continuar o exercício. Avaliamos TnT-as na linha de base e 3 horas após a SEAA. O protocolo consistiu em 5 minutos de aquecimento, 30 minutos de exercício aeróbico contínuo na frequência cardíaca correspondente ao limiar anaeróbio ou limiar de angina obtido no teste de esforço cardiopulmonar e 5 minutos de resfriamento. Foram considerados estatisticamente significativos valores de p menores que 0,05. Resultados Foram incluídos 32 pacientes com AR (61 ± 9 anos, 59,4% do sexo masculino). A concentração basal de TnT-as foi de 10,9 ng/L (intervalo de confiança de 95%: 9,1 a 13,0 ng/L). A TnT-as coletada 3 horas após a SEAA foi de 11,1 ng/L (intervalo de confiança de 95%: 9,1 a 13,5 ng/L). Nenhuma diferença ocorreu na TnT-as antes e após a SEAA (p = 0,657). Conclusões Uma única SEAA realizada no limiar de angina com correspondente escala visual de dor não alterou a TnT-as em pacientes com AR, sugerindo que nenhuma lesão miocárdica significativa foi provocada pelo exercício e que este protocolo de exercício pode ser considerado seguro.


Abstract Background It is unclear whether exercise is safe in patients with more advanced forms of coronary artery disease, such as those with refractory angina (RA). Objective We aimed to determine the effect of an acute aerobic exercise session (AAES) on high-sensitivity cardiac troponin T (hs-cTnT) levels in patients with RA. Methods This was a longitudinal, non-randomized, and non-controlled clinical study. Participants were recruited from April 2015 to January 2019. On a visual pain scale from 0 to 10, pain rated up to 3 was considered as the top level allowed to continue exercising. We assessed hs-cTnT at baseline and 3 hours after the AAES. The protocol consisted of 5 minutes of warm-up, 30 minutes of continuous aerobic exercise at heart rate corresponding to the anaerobic threshold or angina threshold obtained in the cardiopulmonary exercise testing, and 5 minutes of cooling down. P values less than 0.05 were considered statistically significant. Results Thirty-two patients with RA were included (61 ± 9 years, 59.4% male). The baseline hs-cTnT concentration was 10.9 ng/L (95% confidence interval: 9.1 to 13.0 ng/L). The hs-cTnT collected 3 hours after the AAES was 11.1 ng/L (95% confidence interval: 9.1 to 13.5 ng/L). No difference occurred in hs-cTnT before and after AAES (p = 0.657). Conclusions A single AAES performed at the angina threshold with corresponding visual pain scale did not alter hs-cTnT in patients with RA, suggesting that no significant myocardial injury was elicited by exercising and that this exercise protocol can be considered safe.

7.
Rev. bras. med. esporte ; 28(5): 469-473, Set.-Oct. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1376709

ABSTRACT

ABSTRACT Introduction: The changes in brain structure caused by a sports-related concussion may initially be indistinguishable, however, the irreversible deleterious effects are noted in the long term. An early diagnosis may provide the patient with a better recovery chance and increased survival. For this purpose, this paper studies the feasibility of a diagnosis for concussion by microRNA (mi-RNA) biomarkers contained in the saliva of athletes. Objective: Verify whether salivary miRNAs could be considered good biomarkers for sports concussion. Methodology: Salivary mi-RNA levels were determined from 120 saliva samples of 120 players. There were 43 with a diagnosis of concussion and 77 without a diagnosis of concussion. Samples from players with a concussion were collected 30 minutes prior to activity, samples from individuals who did not engage in physical activity were also compared. Results: On the evaluation of 30 miRNA from individuals with a concussion between contact and non-contact sports there was high detection reliability(P<.05). Both miR-532-5p and miR-182-5p showed reduced amounts of physical activity. The miRNA-532-5p and miRNA-182-5p show significant results among 43 subjects from pre-exercise to post-exercise. The miRNA-4510 showed a significant result (p < 0.05) between contact and non-contact sport types. The amount of miRNA-4510 expanded in 20 individuals in the contact sport at post-exercise but remained normal in the non-contact sports group. Conclusion: The salivary miRNAs are reliable biomarkers for concussion. Evidence Level II; Therapeutic Studies - Investigating the results.


RESUMO Introdução: As alterações da estrutura cerebral provocadas por uma concussão relacionada ao esporte podem ser inicialmente indistinguíveis, porém os efeitos deletérios irreversíveis são notados a longo prazo. Um diagnóstico precoce poderá fornecer ao paciente uma chance maior de recuperação e aumento de sobrevida. Para tanto, estuda-se a viabilidade de um diagnóstico de concussão por biomarcadores de micro RNA (mi-RNA) contidos na saliva de esportistas. Objetivo: verificar se os miRNAs salivares são biomarcadores confiáveis para concussão esportiva. Metodologia: Os níveis de mi-RNA salivares foram determinados a partir de 120 amostras de saliva de 120 jogadores. Haviam 43 com diagnóstico de concussão e 77 sem diagnóstico de concussão. Amostras de jogadores com concussão foram coletadas 30 minutos antes da atividade, amostras de indivíduos que não praticaram atividade física também foram comparadas. Resultados: Na avaliação de 30 mi-RNA de indivíduos com concussão entre esportes de contato e sem contato houve grande confiabilidade de detecção(P<,05). Tanto o miR-532-5p quanto o miR-182-5p mostraram quantidades reduzidas na atividade física. O miRNA-532-5p e o miRNA-182-5p mostram resultados significativos entre 43 indivíduos desde o pré-exercício até o pós-exercício. O miRNA-4510 mostrou um resultado significativo (p < 0,05) entre os tipos de esporte com contato e sem contato. A quantidade de mi-RNA-4510 expandiu-se em 20 pessoas no esporte com contato no pós-exercício, mas permaneceu normal no grupo de esporte sem contato. Conclusão: Conclui-se que os miRNAs salivares são biomarcadores confiáveis para concussão. Nível de evidência II; Estudos Terapêuticos - Investigação de Resultados.


RESUMEN Introducción: Los cambios en la estructura cerebral causados por una conmoción encefálica relacionada con el deporte pueden ser inicialmente indistintos, sin embargo, los efectos deletéreos irreversibles se manifiestan a largo plazo. Un diagnóstico anticipado puede proporcionar al paciente una mayor posibilidad de recuperación y una mayor supervivencia. Por lo tanto, se estudia la viabilidad de un diagnóstico de conmoción encefálica mediante los biomarcadores de microARN (mi-ARN) contenidos en la saliva de los deportistas. Objetivo: verificar si los miARN salivales son biomarcadores fiables para la conmoción encefálica deportiva. Metodología: Se determinaron los niveles de mi-ARN salival a partir de 120 muestras de saliva de 120 jugadores. Había 43 con diagnóstico de conmoción encefálica y 77 sin diagnóstico de conmoción encefálica. Las muestras de los jugadores con conmoción encefálica se recogieron 30 minutos antes de la actividad, también se compararon las muestras de los individuos que no practicaban actividad física. Resultados: En la evaluación de 30 miRNA de individuos con conmoción encefálica entre deportes de contacto y sin contacto hubo una alta fiabilidad de detección (P<.05). Tanto miR-532-5p como miR-182-5p mostraron cantidades reducidas en la actividad física. El miRNA-532-5p y el miRNA-182-5p muestran resultados significativos entre los 43 sujetos desde antes del ejercicio hasta después del mismo. El miRNA-4510 mostró un resultado significativo (p < 0,05) entre los tipos de deporte de contacto y de no contacto. La cantidad de miARN-4510 se expandió en 20 individuos en el deporte de contacto en el momento posterior al ejercicio, pero se mantuvo normal en el grupo de deporte sin contacto. Conclusión: Llegamos a la conclusión de que los miARN salivales son biomarcadores fiables para la conmoción encefálica. Nivel de evidencia II; Estudios terapéuticos - Investigación de resultados.

9.
Braz. j. otorhinolaryngol. (Impr.) ; 88(5): 683-690, Sept.-Oct. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1403934

ABSTRACT

Abstract Introduction Medication-related osteonecrosis of the jaws is a severe complication of the use of antiresorptive and antiangiogenic therapy, with limited treatment options and great impact on patient's quality pf life. Objective The aim of this study was to assess the risk factors associated with medication-related osteonecrosis of the jaws in oncologic patients undergoing bisphosphonate treatment. In addition, salivary levels of interleukin-6, IL-6, were measured to investigate their association with severity and risk of medication-related osteonecrosis of the jaws. Methods Case-control study with 74 patients with bone metastases from solid tumors and multiple myeloma was included. Patients were divided into three groups: 1) those undergoing bisphosphonate treatment with medication-related osteonecrosis of the jaws; 2) those undergoing bisphosphonate without medication-related osteonecrosis of the jaws; and 3) those with bisphosphonate pretreatment. The demographic and medical data of the patients were collected to assess risk. The clinical evaluation was performed to diagnose medication-related osteonecrosis of the jaws and unstimulated saliva was collected for quantification of IL-6. Results As result, it was observed that patients diagnosed with medication-related osteonecrosis of the jaws were submitted to higher number of bisphosphonate doses (p= 0.001) and monthly infusion protocol (p= 0.044; OR = 7.75). Patients who did not have routine followup with specialized dentists during therapy with bisphosphonate and smoking were associated with medication-related osteonecrosis of the jaws (p= 0.019; OR = 8.25 and p= 0.031; OR = 9.37 respectively). Group 1 had a higher frequency of treatment with chemotherapy and corticosteroids concomitant with bisphosphonate, and surgical dental procedures (p= 0.129). Salivary IL-6 levels showed no statistically significant difference between the groups (p= 0.571) or association with medication-related osteonecrosis of the jaws severity (p= 0.923). Conclusion A higher number of bisphosphonate cycles, monthly infusion protocol, no dental follow-up for oral health maintenance and smoking were associated with medication-related osteonecrosis of the jaws. Specialized dental follow up during bisphosphonate treatment has been shown to be an important factor in preventing this complication.


Resumo Introdução A osteonecrose dos maxilares relacionada à medicação é uma complicação grave da terapia antirreabsortiva e antiangiogênica, com opção de tratamento limitada e grande impacto na qualidade de vida do paciente. Objetivo Avaliar os fatores de risco associados à osteonecrose dos maxilares relacionada à medicação em pacientes oncológicos em tratamento com bifosfonato Além disso, os níveis salivares de interleucina-6 (IL-6) foram medidos para investigar sua associação com a gravidade e o risco de osteonecrose dos maxilares relacionada à medicação. Método Estudo caso-controle com 74 pacientes com metástases ósseas de tumores sólidos e mieloma múltiplo. Os pacientes foram divididos em três grupos: 1) em tratamento por bifosfonato com osteonecrose dos maxilares relacionada à medicação; 2) submetidos ao bifosfonato sem osteonecrose dos maxilares relacionada à medicação; e 3) pré-tratamento de bifosfonato. Os dados demográficos e médicos dos pacientes foram coletados para avaliar o risco. A avaliação clínica foi feita para diagnosticar osteonecrose dos maxilares relacionada à medicação e a saliva não estimulada foi coletada para quantificação da IL-6. Resultados Observou-se que os pacientes diagnosticados com osteonecrose dos maxilares relacionada à medicação foram submetidos a maior número de doses de bifosfonato (p = 0,001) e protocolo de infusão mensal (p = 0,044; OR = 7,75). Pacientes que não tiveram acompanhamento de rotina com dentistas especializados durante a terapia com bifosfonato e tabagismo foram associados ao osteonecrose dos maxilares relacionada à medicação (p = 0,019; OR = 8,25 e p = 0,031; OR = 9,37, respectivamente). O grupo 1 apresentou maior frequência de tratamento com quimioterapia e corticosteroides concomitantes ao bifosfonato e procedimentos odontológicos cirúrgicos (p = 0,129). Os níveis salivares de IL-6 não apresentaram diferença estatisticamente significante entre os grupos (p = 0,571) ou associação com a gravidade do osteonecrose dos maxilares relacionada à medicação (p = 0,923). Conclusão Maior número de ciclos de bifosfonato, protocolo de infusão mensal, ausência de acompanhamento odontológico para manutenção da saúde bucal e tabagismo foram associados ao osteonecrose dos maxilares relacionada à medicação. O acompanhamento odontológico especializado durante o tratamento demonstrou ser importante na prevenção dessa complicação.

10.
Rev. bras. cir. cardiovasc ; 37(5): 674-679, Sept.-Oct. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1407286

ABSTRACT

ABSTRACT Introduction: Prosthetic valve dysfunction is a potentially critical complication of heart valve replacement. An easy and quickly applicable diagnostic procedure is required for recognizing the prosthetic valve dysfunction. The purpose of this study was to prospectively define the diagnostic value of D-dimer and INR level in predicting prosthetic valve dysfunction. Methods: This cross-sectional study was performed in 70 patients suspected to have prosthetic valve dysfunction admitted to Imam Ali Hospital, affiliated with Kermanshah University of Medical Sciences (KUMS), Kermanshah Province, Iran. Cinefluoroscopy, as the gold standard diagnostic test, was used for the diagnosis of prosthetic valve dysfunction in enrolled patients. Two milliliters of blood from each patient were taken into a tube containing sodium citrate anticoagulant. To evaluate D-dimer, the cutoff value was set at 500 ng/ml. Also, to evaluate international normalized ratio (INR), the cutoff value was set at 2. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) of the serum markers were used to describe predictive properties. Results: Of 70 patients, 27 (38.6%) were male and 43 (61.4%) were female, and the mean age was 54.67±15.11 years (range, 18 to 80 years). Of 70 patients, 27 (38.6%) had prosthetic heart valve malfunction demonstrable by fluoroscopy, and 19 patients (27.1%) had D-dimer levels >500 ng/ml. Elevated D-dimer levels (>500 ng/ml) have been indicated to have sensitivity of 70.4%, and hence an NPV of 84.3%, specificity of 100%, PPV of 100%, NLR of 0.3, and the infinity value of PLR for predicting prosthetic valve dysfunction. There was a significant relationship between fluoroscopy and D-dimer test (P=0.001). A kappa coefficient value of 0.745 indicated a substantial agreement between D-dimer and fluoroscopy testing. Mixing test (combination of D-dimer and INR) showed to have 100% sensitivity, and hence a NPV of 69.8%, specificity of 69.8%, PPV of 51.8%, NLR of 1.41, and PLR of 1.44 for predicting prosthetic valve dysfunction. Conclusion: D-dimer with moderate sensitivity and high specificity is an ideal marker for the diagnosis of prosthetic valve dysfunction in suspected patients. Enhanced plasma D-dimer level is not by itself diagnostic of a prosthetic valve dysfunction but may alert physicians to refer the patient for more detailed examination, preferably by fluoroscopy. Mixing test with 100% sensitivity can apply as a rule-out test.

11.
Säo Paulo med. j ; 140(5): 691-696, Sept.-Oct. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1410216

ABSTRACT

ABSTRACT BACKGROUND: Clinical judgment of initial baseline laboratory tests plays an important role in triage and preliminary diagnosis among coronavirus disease 2019 (COVID-19) patients. OBJECTIVES: To determine the differences in laboratory parameters between COVID-19 and COVID-like patients, and between COVID-19 and healthy children. Additionally, to ascertain whether healthy children or patients with COVID-like symptoms would form a better control group. DESIGN AND SETTING: Cross-sectional study at the Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia. METHODS: A retrospective study was conducted on 42 pediatric patients of both sexes with COVID-19. Hematological parameters (white blood cell count, absolute lymphocyte count and platelet count) and biochemical parameters (natremia, kalemia, chloremia, aspartate aminotransferase [AST], alanine aminotransferase [ALT], lactate dehydrogenase [LDH] and C-reactive protein [CRP]) were collected. The first control group was formed by 80 healthy children and the second control group was formed by 55 pediatric patients with COVID-like symptoms. RESULTS: Leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutrophil-lymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP were present in COVID patients, in comparison with healthy controls, while in comparison with COVID-like controls only lymphopenia was determined. CONCLUSIONS: The presence of leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutrophil-lymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP may help healthcare providers in early identification of COVID-19 patients. Healthy controls were superior to COVID-like controls since they provided better insight into the laboratory characteristics of children with novel betacoronavirus (SARS-CoV-2) infection.

12.
Rev. Hosp. Ital. B. Aires (2004) ; 42(3): 143-151, sept. 2022. graf, ilus, tab
Article in Spanish | LILACS, BINACIS, UNISALUD | ID: biblio-1396799

ABSTRACT

Introducción: en diciembre del año 2019 surgió en China una neumonía viral; el virus fue identificado como un coronavirus SARS-CoV-2, que se propagó rápidamente de tal manera que se convirtió en pandemia. La alta contagiosidad y la presencia de portadores asintomáticos dificultaron el diagnóstico de la infección y la toma de decisiones sanitarias. Objetivo: el objetivo de esta revisión bibliográfica es presentar y describir las principales técnicas utilizadas actualmente para el diagnóstico de COVID-19 y establecer su relación con los conocimientos de distintas disciplinas y tecnologías emergentes que confluyen en la Biotecnología bioquímico-farmacéutica orientada a la Salud humana. Metodología: se realizó una revisión de la bibliografía disponible en PubMed a partir de enero de 2020 sobre las pruebas diagnósticas que se encuentran actualmente en uso, en el ámbito sanitario, para la detección y seguimiento de la enfermedad COVID-19. También se realizaron búsquedas a través de Google y Google Académico para publicaciones de organismos de Salud en referencia a métodos diagnósticos. Resultados: se presenta una importante cantidad de pruebas diagnósticas, basadas en diferentes tecnologías, que desempeñan un papel clave en la pandemia de COVID-19. Algunas de ellas muy sofisticadas, como la secuenciación genómica de próxima generación, otras más estándar, pero igualmente robustas, como la reacción en cadena de la polimerasa (PCR). También otras adaptadas para el brote pandémico, como la amplificación isotérmica de ácidos nucleicos mediada por bucle. Todas las mencionadas se consideran de tipo molecular, pero también existen las pruebas serológicas, como ELISA, que incluyen ensayos en plasma o de tipo inmunológico. Estas sirven para detectar anticuerpos frente a la exposición al virus o antígenos en personas potencialmente infectadas. Conclusiones: los procesos de investigación y desarrollo biotecnológicos aplicados al diagnóstico y los conocimientos científicos previos permitieron una respuesta tanto nacional como internacional rápida y eficaz en medio de una inédita pandemia global. En esta revisión destacamos las principales técnicas, en qué estadio se deben usar y qué información nos aportan. (AU)


Introduction: in December 2019, a viral pneumonia emerged in China, identifying the virus as a SARS-CoV-2 coronavirus, which spread rapidly in such a way that it became a pandemic. The high contagiousness and the presence of asymptomatic carriers make difficulted to diagnose the infection and to make health decisions. Target: the objective of this review is to present and describe the main techniques currently used for the diagnosis of COVID-19, and to establish their relationship with the knowledge of different disciplines and emerging technologies that converge in biochemical-pharmaceutical biotechnology oriented to human health. Methodology: a review of the literature available in Pubmed from January 2020 on the diagnostic tests that are currently in use in the health field, for the detection and monitoring of COVID-19 disease, was carried out. Searches were also carried out through Google and Google Scholar for publications of Health organizations in reference to diagnostic methods. Results: a significant number of diagnostic tests are presented, based on different technologies, which play a key role in the COVID-19 pandemic. Some of them are very sophisticated, such as next-generation genomic sequencing, others more standard, but equally robust, such as polymerase chain reaction. Also others adapted for the pandemic outbreak such as loop-mediated isothermal amplification of nucleic acids. All of the aforementioned are considered molecular, but there are also serological tests, such as ELISA, which include plasma or immunological tests. These serve to detect antibodies against exposure to the virus or antigens in potentially infected people. Conclusions: biotechnological research and development processes applied to diagnosis and previous scientific knowledge allowed a rapid and effective national and international response in the midst of an unprecedented global pandemic. In this review we highlight the main techniques, at what stage they should be used and what information they provide us. (AU)


Subject(s)
Humans , Biotechnology/trends , COVID-19 Testing/methods , SARS-CoV-2/isolation & purification , COVID-19/diagnosis , Enzyme-Linked Immunosorbent Assay , Biomarkers , Sensitivity and Specificity , Diagnostic Techniques and Procedures , COVID-19 Nucleic Acid Testing , COVID-19 Serological Testing
14.
J. pediatr. (Rio J.) ; 98(5): 526-532, Sept.-Oct. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1405487

ABSTRACT

Abstract Objective The aim of this study was to evaluate the serum Syndecan-1 (SDC-1) levels in patients with immunoglobulin-A vasculitis (IgAV) in children and its relation with gastrointestinal involvements. Methods Sixty-eight children with IgAV and 48 healthy children were enrolled in this cross-sectional study. Clinical and related laboratory data were collected from a computerized hospital database. Serum SDC-1 was collected on admission prior to treatment. Results Forty-eight patients fully met the IgAV diagnostic criteria at admission (IgAV group), 20 patients with rash only and diagnosed IgAV during hospitalization (Purpura group). In IgAV group, 30 patients with gastrointestinal involvements (IgAV-GI group) and 18 patients without gastrointestinal involvements (IgAV-NGI group). SDC-1 serum levels were significantly higher in the IgAV group (86.37 ng/mL (IQR 59.16-117.14 ng/mL)) than in the controls (20.37 ng/mL (IQR 15.52-26.45 ng/mL)) and the Purpura group (32.66 ng/mL (IQR 14.87-49.89 ng/mL)). Additionally, SDC-1 (OR = 1.08) was independently associated with IgAV with a cut-off value (sensitivity and specificity) of 66.55 ng/mL (68.8%, 95.0%), and the area under the curve was 0.908. The serum SDC-1 levels of the IgAV-GI group (106.92 ± 50.12 ng/mL) were significantly higher than those in the IgAV-NGI group (67.52 ± 17.59 ng/mL). Logistic regression analysis showed that SDC-1 (OR = 1.03) was independently associated with IgAV-GI with a cut-off value of 89.39 ng/mL. Conclusions SDC-1 serum levels may mirror vascular endothelium injury and mucosal damage in IgAV. Its applicability as a surrogate biomarker in IgAV remains to be determined.

15.
Medicentro (Villa Clara) ; 26(3): 614-636, jul.-set. 2022. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1405660

ABSTRACT

RESUMEN Introducción: El trasplante renal es la mejor opción disponible para el tratamiento de la insuficiencia renal crónica terminal. La determinación de marcadores humorales permite detectar y seguir la evolución del paciente trasplantado renal y la disfunción del injerto, así como sus diversas complicaciones. Objetivos: Relacionar el funcionamiento del trasplante renal realizado a pacientes con un grupo de marcadores humorales. Métodos: Se realizó una investigación descriptiva y de corte transversal en 85 pacientes trasplantados renales, previo consentimiento informado, los cuales constituían la totalidad de los pacientes del Servicio de trasplante renal, en el Hospital Universitario Clínico-Quirúrgico «Arnaldo Milián Castro¼, Santa Clara, Villa Clara, desde enero de 2015 a diciembre de 2017. Resultados: Predominaron pacientes del sexo masculino, de 40-59 años de edad. La principal enfermedad asociada fue la hipertensión arterial. Del total de trasplantados estaban con funcionabilidad 62 pacientes (72,94 %) y en ellos, fue significativo el aumento de los valores de hematocrito y albúmina, así como el valor medio de la creatinina sérica, ligeramente superior a los valores de referencia. Conclusiones: El rango de edad más frecuente fue de 40-59 años. Prevaleció el sexo masculino asociado con la hipertensión arterial. Predominó la funcionabilidad de los trasplantes realizados precozmente, con menor tiempo en diálisis. En los marcadores humorales la creatinina presentó una asociación significativa. Por otra parte, el hematocrito nunca se normalizó en los no funcionales. El conteo de Addis fue el examen que más modificación precoz sufrió ante cualquier alteración en la función renal.


ABSTRACT Introduction: renal transplantation is the best available option for the treatment of terminal chronic renal failure. The determination of humoral markers makes it possible to detect and follow the evolution of kidney transplant patients and graft dysfunction, as well as its various complications. Objectives: to relate the performance of kidney transplants performed in patients with a group of humoral markers. Methods: a descriptive and cross-sectional research was carried out in 85 kidney transplant patients, with prior informed consent, which constituted all the patients of the Kidney Transplant service from "Arnaldo Milián Castro" Clinical and Surgical University Hospital, Santa Clara, Villa Clara, between January 2015 and December 2017. Results: male patients aged 40-59 years old predominated. The main associated disease was arterial hypertension. A number of 62 patients from the total number of transplant recipients (72.94%) were functional and the increase in hematocrit and albumin values ​​was significant in them, as well as the mean value of serum creatinine was slightly higher than the reference values. Conclusions: the most frequent age range was 40-59 years. The male gender associated with arterial hypertension prevailed. The functionality of transplants performed early, with less time on dialysis, prevailed. Creatinine had a significant association in the humoral markers. On the other hand, the hematocrit never normalized in non-functional patients. The Addis count was the test that underwent the earliest changes in the event of any alteration in renal function.

16.
Rev. chil. neuro-psiquiatr ; 60(3)sept. 2022.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1407820

ABSTRACT

RESUMEN: Los biomarcadores más estudiados en la demencia tipo Alzheimer (DA) son los niveles elevados de Aβ42 y de proteína Tau en líquido cefalorraquídeo. Dada la complejidad de la sintomatología cognitiva y síntomas neuropsiquiátricos (SNP) de esta patología, algunos estudios recientes proponen sustancias como las orexinas, como blanco terapéutico de DA y SNP. El presente trabajo tiene como objetivo revisar publicaciones científicas recientes que hayan analizado la asociación entre orexinas, SNP y DA en humanos, algunos modelos animales y que hayan evaluado a las orexinas como posibles biomarcadores tanto para investigación como en el área clínica. En esta revisión también se describen los estudios que sugieren a las orexinas como un posible biomarcador en la DA, dada su relación con el Aβ42 y la proteína Tau, y otros estudios que las asocian con presencia de SNP, especialmente alteración del sueño. Se plantea la hipótesis de que la presencia de SNP en DA se asocia con las orexinas, debido a que este sistema influye en el funcionamiento hipotalámico y de forma indirecta en áreas cerebrales que regulan el comportamiento. Sin embargo, aún falta mayor investigación, principalmente de estudios longitudinales para conocer claramente la influencia de las orexinas en los SNP.


ABSTRACT The most studied biomarkers in Alzheimer's dementia (AD) are elevated levels of Aβ42 and Tau protein in cerebrospinal fluid. Given the complexity of the cognitive symptomatology and neuropsychiatric symptoms (NPS) of this pathology, some recent studies propose substances such as orexins as a therapeutic target for AD and NPS. The present work aims to review recent scientific publications that have analyzed the association between orexins, PNS and AD in humans. There are some animal models that have evaluated orexins as possible biomarkers both for research and in the clinical area. This review also describes studies that suggest orexins as possible biomarkers in AD, given their relationship with Aβ42 and Tau protein, and other studies that associate them with the presence of SNPs, especially sleep disturbance. It is hypothesized that the presence of SNPs in AD is associated with orexins, because this system influences hypothalamic functioning and indirectly in brain areas that regulate behavior. However, further research is still lacking, mainly longitudinal studies to clearly know the influence of orexins on SNPs.

18.
Rev. bras. cir. cardiovasc ; 37(4): 481-487, Jul.-Aug. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1394721

ABSTRACT

ABSTRACT Introduction: Presenilin 1 (PSEN1), catalase (CAT), glutathione-S-transferase (GST) and paraoxonase 1 (PON1) play a vital role in prediction, diagnosis and therapy of metabolic disorders. Methods: Metabolic enzyme activities and lipid peroxidation in serum of cerebrovascular diseases (CVD) and coronary artery diseases were measured by spectrophotometric methods. mRNA was isolated from leukocytes of the patient group and healthy adult patients. Quantitative gene expression of PSEN1, CAT and GST mRNA was identified by quantitative real-time polymerase chain reaction (qPCR). Results: The PSEN1, CAT and GST expression in patients showed significant differences compared to the control group. PSEN1 expression in leukocytes was significantly about twice as high as that of the control group in patients with CVD. The GST, CAT and PON1 activity showed significant differences in patient groups compared to the control group. Conclusion: The mRNA expression levels can be used as a potential biomarker in the diagnosis of atherosclerosis that occurs as a result of the metabolic disorder. In atherosclerotic patients, antioxidant status is independently related to an increased risk of cardiovascular events. Antioxidant activities and mRNA expressions may have predictive value, as well as available risk factors.

20.
Gac. méd. Méx ; 158(4): 244-251, jul.-ago. 2022. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1404847

ABSTRACT

Resumen La enfermedad de Alzheimer es un desorden neurodegenerativo cuya etiología aún se discute, al punto de que existen diferentes hipótesis que pretenden esclarecerla; además, dada su naturaleza multifactorial, existen diferentes factores de riesgo asociados a su desarrollo. Respecto al diagnóstico, los avances en las técnicas de detección de moléculas a escalas femtomolares han permitido discernir entre sujetos sanos y enfermos en estadios relativamente tempranos, aunque todavía hay mucho por hacer. Aducanumab es un anticuerpo monoclonal dirigido contra Aβ, cuya aprobación por parte de la Food and Drug Administration para comercializarse ha sido cuestionada por la comunidad médica internacional, dados los resultados controversiales en los ensayos clínicos. La aprobación de este anticuerpo como tratamiento modificador de la enfermedad de Alzheimer abre la puerta para seguir utilizando este tipo de tratamientos, pero con blancos terapéuticos diferentes, como, por ejemplo, la proteína tau. Finalmente, dada la tendencia de la población hacia la longevidad, padecimientos como la enfermedad de Alzheimer están tomando importancia epidemiológica, por lo que resulta imperativo analizar y vincular lo que se está haciendo en los ámbitos social, familiar, clínico y de investigación y, sobre todo, encontrar esas áreas de oportunidad en beneficio del paciente.


Abstract Alzheimer's disease is a neurodegenerative disorder whose etiology continues to be discussed, to the point that there are different hypotheses that seek to clarify it, in addition to the fact that, given its multifactorial nature, there are different risk factors associated with its development. As regards diagnosis, advances in molecule detection techniques at femtomolar scales have allowed to distinguish between healthy and diseased subjects at relatively early stages, although there is still much to be done. Aducanumab is a monoclonal antibody targeted against Aβ, whose marketing approval by the Food and Drug Administration has been questioned by the international medical community, given the controversial results in clinical trials. Approval of this antibody as a disease-modifying treatment for Alzheimer's disease opens the door to continue using this type of treatments, but with different therapeutic targets, such as, for example, tau protein. Finally, given the population tendency towards longevity, conditions such as Alzheimer's disease are gaining epidemiological importance, which is why it is imperative to analyze and link what is being done in the social, familiar, clinical and research fields and, most importantly, to find those areas of opportunity for the benefit of the patient.

SELECTION OF CITATIONS
SEARCH DETAIL